Financhill
Sell
41

PHM Quote, Financials, Valuation and Earnings

Last price:
$119.31
Seasonality move :
17.15%
Day range:
$116.93 - $119.85
52-week range:
$88.07 - $142.11
Dividend yield:
0.77%
P/E ratio:
9.19x
P/S ratio:
1.37x
P/B ratio:
1.81x
Volume:
891.4K
Avg. volume:
1.8M
1-year change:
7.77%
Market cap:
$23.3B
Revenue:
$17.9B
EPS (TTM):
$12.99

Earnings Data

Next earnings date for PHM
Jan 29
2026
Most recent earnings per share
$2.96
Beat by $0.07
(Oct 21/2025)
Consensus Estimate
$2.89
(Oct 21/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PHM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/29/2026 Q4 $4.3B -- -- $2.81 --
10/21/2025 Q3 $4.3B $4.4B $2.96 $2.89 $0.07
07/22/2025 Q2 $4.4B $4.4B $3.03 $2.93 $0.10
04/22/2025 Q1 $3.8B $3.9B $2.57 $2.44 $0.12
01/30/2025 Q4 $4.6B $4.9B $4.43 $3.27 $1.16
10/22/2024 Q3 $4.3B $4.5B $3.35 $3.18 $0.17
07/23/2024 Q2 $4.5B $4.6B $3.83 $3.27 $0.56
04/23/2024 Q1 $3.6B $3.9B $3.10 $2.36 $0.75
01/30/2024 Q4 $4.5B $4.3B $3.28 $3.23 $0.05
10/24/2023 Q3 -- $4B $2.90 -- --
07/25/2023 Q2 -- $4.2B $3.21 -- --
04/25/2023 Q1 -- $3.6B $2.35 -- --
01/31/2023 Q4 -- $5.1B $3.84 -- --
10/25/2022 Q3 -- $3.9B $2.69 -- --
07/26/2022 Q2 -- $3.9B $2.73 -- --
04/28/2022 Q1 -- $3.1B $1.83 -- --
02/01/2022 Q4 -- $4.4B $2.61 -- --
10/26/2021 Q3 -- $3.5B $1.82 -- --
07/27/2021 Q2 -- $3.4B $1.90 -- --
04/27/2021 Q1 -- $2.7B $1.13 -- --
01/28/2021 Q4 -- $3.2B $1.62 -- --
10/22/2020 Q3 -- $3B $1.54 -- --
07/23/2020 Q2 -- $2.6B $1.29 -- --
04/23/2020 Q1 -- $2.3B $0.74 -- --
01/28/2020 Q4 -- $3B $1.22 -- --
10/22/2019 Q3 -- $2.7B $0.99 -- --
07/23/2019 Q2 -- $2.5B $0.86 -- --
04/23/2019 Q1 -- $2B $0.59 -- --
01/29/2019 Q4 -- $3B $0.84 -- --
10/23/2018 Q3 -- $2.6B $1.01 -- --
07/26/2018 Q2 -- $2.6B $1.12 -- --
04/24/2018 Q1 -- $2B $0.59 -- --
01/30/2018 Q4 -- $2.8B $0.26 -- --
10/24/2017 Q3 -- $2.1B $0.58 -- --
07/25/2017 Q2 -- $2B $0.32 -- --
04/25/2017 Q1 -- $1.6B $0.28 -- --
01/26/2017 Q4 -- $2.5B $0.83 -- --
10/20/2016 Q3 -- $1.9B $0.37 -- --
07/21/2016 Q2 -- $1.8B $0.34 -- --
04/21/2016 Q1 -- $1.4B $0.24 -- --
01/28/2016 Q4 -- $2.1B $0.64 -- --

PulteGroup, Inc. Earnings Questions

  • How Much did PulteGroup, Inc. Generate in Revenue Last Quarter?

    PulteGroup, Inc. reported $4.4B worth of top line sales in its most recent quarter.

  • Did PulteGroup, Inc. Beat Earnings Last Quarter?

    PulteGroup, Inc. announced earnings per share of $2.96 which represents a beat of analyst forecast a $2.89 per share.

  • Is PulteGroup, Inc. Profitable?

    PulteGroup, Inc. reported $1.2B that represents $5.86 per share over the last quarter.

  • What is the Analyst Consensus for PulteGroup, Inc. EPS Next Year?

    PulteGroup, Inc.'s earnings are forecast to decrease from $14.69 per share to $13.25 per share next year representing a decrease of -22.69%.

  • When is PulteGroup, Inc.'s Earnings Date?

    PulteGroup, Inc.'s next earnings date is January 29, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock